Audio recording of Investors/ Analyst conference call on the audited consolidated and standalone financial results of the Company for the quarter and financial year ended March 31, 2026,.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech has notified exchanges that the audio recording of its investor/analyst conference call for Q4 and FY2026 results (audited, consolidated and standalone) has been uploaded to the company website. The transcript will be shared with exchanges and uploaded on the website subsequently. This is a routine regulatory intimation under SEBI Listing Regulations, following an earlier letter dated May 18, 2026. No new financial figures or strategic details are contained in this filing.
This is a procedural disclosure; it confirms the company held an earnings call and is making materials accessible to investors, but carries no standalone price-sensitive information.